Page last updated: 2024-11-05

tolbutamide and Myocarditis

tolbutamide has been researched along with Myocarditis in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WELLMAN, KF1
LAZARUS, SS1
VOLK, BW1

Other Studies

1 other study available for tolbutamide and Myocarditis

ArticleYear
THE VISCERA IN SULFONYLUREA-TREATED DIABETICS.
    Metabolism: clinical and experimental, 1963, Volume: 12

    Topics: Chlorpropamide; Diabetes Mellitus; Granuloma; Heart Diseases; Insulin; Kidney Diseases; Liver Diseas

1963